118 related articles for article (PubMed ID: 10025902)
1. Bryostatin-1 and 1alpha,25-dihydroxyvitamin D3 synergistically stimulate the differentiation of NB4 acute promyelocytic leukemia cells.
Song XD; Norman AW
Leukemia; 1999 Feb; 13(2):275-81. PubMed ID: 10025902
[TBL] [Abstract][Full Text] [Related]
2. 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression.
Clark CS; Konyer JE; Meckling KA
Exp Cell Res; 2004 Mar; 294(1):301-11. PubMed ID: 14980523
[TBL] [Abstract][Full Text] [Related]
3. 1Alpha,25-dihydroxyvitamin D3 and phorbol ester mediate the expression of alkaline phosphatase in NB4 acute promyelocytic leukemia cells.
Song X; Norman AW
Leuk Res; 1998 Jan; 22(1):69-76. PubMed ID: 9585082
[TBL] [Abstract][Full Text] [Related]
4. M-CSF and 1,25 dihydroxy vitamin D3 synergize with 12-O-tetradecanoylphorbol-13-acetate to induce macrophage differentiation in acute promyelocytic leukemia NB4 cells.
Bhatia M; Kirkland JB; Meckling-Gill KA
Leukemia; 1994 Oct; 8(10):1744-9. PubMed ID: 7934171
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of phosphorylation of mitogen-activated protein kinase by 1alpha,25-dihydroxyvitamin D3 in promyelocytic NB4 leukemia cells: a structure-function study.
Song X; Bishop JE; Okamura WH; Norman AW
Endocrinology; 1998 Feb; 139(2):457-65. PubMed ID: 9449611
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of inducible nitric oxide (NO) synthase and NO production in HL-60 cells stimulated to differentiate by phorbol 12-myristate 13-acetate plus 1,25-dihydroxyvitamin D3 is not obtained with dimethylsulfoxide plus 1,25-dihydroxyvitamin D3.
Kawase T; Orikasa M; Oguro A; Burns DM
Calcif Tissue Int; 1998 Jul; 63(1):27-35. PubMed ID: 9632843
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 and phorbol myristate acetate produce divergent phenotypes in a monomyelocytic cell line.
Biskobing DM; Rubin J
Endocrinology; 1993 Feb; 132(2):862-6. PubMed ID: 8425498
[TBL] [Abstract][Full Text] [Related]
8. Dibutyryl cAMP enhances the effect of 1,25-dihydroxyvitamin D3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps.
Inaba M; Okuno S; Koyama H; Nishizawa Y; Morii H
Arch Biochem Biophys; 1992 Feb; 293(1):181-6. PubMed ID: 1309983
[TBL] [Abstract][Full Text] [Related]
9. Modulation of gene expression in the acute promyelocytic leukemia cell line NB4.
Hu ZB; Ma W; Uphoff CC; Lanotte M; Drexler HG
Leukemia; 1993 Nov; 7(11):1817-23. PubMed ID: 7901456
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 stimulates expression and translocation of protein kinase Calpha and Cdelta via a nongenomic mechanism and rapidly induces phosphorylation of a 33-kDa protein in acute promyelocytic NB4 cells.
Berry DM; Antochi R; Bhatia M; Meckling-Gill KA
J Biol Chem; 1996 Jul; 271(27):16090-6. PubMed ID: 8663234
[TBL] [Abstract][Full Text] [Related]
11. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
12. 1alpha,25-dihydroxyvitamin D(3)-26,23-lactone analogs antagonize differentiation of human leukemia cells (HL-60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells).
Miura D; Manabe K; Gao Q; Norman AW; Ishizuka S
FEBS Lett; 1999 Oct; 460(2):297-302. PubMed ID: 10544253
[TBL] [Abstract][Full Text] [Related]
13. Induced differentiation of human myeloid leukemia cells into M2 macrophages by combined treatment with retinoic acid and 1α,25-dihydroxyvitamin D3.
Takahashi H; Hatta Y; Iriyama N; Hasegawa Y; Uchida H; Nakagawa M; Makishima M; Takeuchi J; Takei M
PLoS One; 2014; 9(11):e113722. PubMed ID: 25409436
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
Grant S; Jarvis WD; Swerdlow PS; Turner AJ; Traylor RS; Wallace HJ; Lin PS; Pettit GR; Gewirtz DA
Cancer Res; 1992 Nov; 52(22):6270-8. PubMed ID: 1423273
[TBL] [Abstract][Full Text] [Related]
15. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
Vrana JA; Saunders AM; Chellappan SP; Grant S
Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
[TBL] [Abstract][Full Text] [Related]
16. Modulation of poly(ADP-ribose) polymerase during neutrophilic and monocytic differentiation of promyelocytic (NB4) and myelocytic (HL-60) leukaemia cells.
Bhatia M; Kirkland JB; Meckling-Gill KA
Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):131-7. PubMed ID: 7755555
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of poly(ADP-ribose) polymerase promotes cell cycle arrest and inhibits neutrophilic differentiation of NB4 acute promyelocytic leukemia cells.
Bhatia M; Kirkland JB; Meckling-Gill KA
Cell Growth Differ; 1996 Jan; 7(1):91-100. PubMed ID: 8788037
[TBL] [Abstract][Full Text] [Related]
18. Monocytic differentiation of acute promyelocytic leukemia cells in response to 1,25-dihydroxyvitamin D3 is independent of nuclear receptor binding.
Bhatia M; Kirkland JB; Meckling-Gill KA
J Biol Chem; 1995 Jul; 270(27):15962-5. PubMed ID: 7608152
[TBL] [Abstract][Full Text] [Related]
19. Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid.
Elstner E; Linker-Israeli M; Le J; Umiel T; Michl P; Said JW; Binderup L; Reed JC; Koeffler HP
J Clin Invest; 1997 Jan; 99(2):349-60. PubMed ID: 9006004
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1alpha-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyurea.
Makishima M; Okabe-Kado J; Honma Y
Br J Cancer; 1998; 77(1):33-9. PubMed ID: 9459143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
